Company page

Nexalis Therapeutics Limited

Nexalis Therapeutics Limited, trading under the ticker NX1, is a public company listed on the Australian market. The company has a market capitalization of approximately AUD 1.94 million. Nexalis focuses on developing innovative therapeutic solutions, contributing to advancements in healthcare.

NX1:ASXUpdated July 25, 2026
Nexalis Therapeutics Limited logo
Ticker
NX1:ASX
Asset type
Stock
Market cap
$1.9M
Sector
Distribution Services
Industry
Medical Distributors
Exchange
ASX
Currency
AUD